|
|
 |
|
Viewing report
|
|
|
|
Emergency Contraception in New Zealand
Euromonitor International, March 2012, Pages: 27
Emergency contraception current retail value growth of 6% in 2011 was higher than the review period CAGR of 5% due to the fact that the unit price of Levonelle increased from NZ$43.89 per pill in 2010 to NZ$45.91 in 2011. During 2009, the Auckland District Health Board spent NZ$300,000 on a trial and paid pharmacies to make Levonelle available for free for five months ending in March 2009. The free pills were distributed to approximately 8,000 patients (even those aged between 10 and 14). As a...
The Emergency Contraception in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Emergency Contraception market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
|
|
|
|
